Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 13/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | HTT | P42858 | 3/20 | 0.43 |
| ▸ | F2 | P00734 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 10/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | RARA | P10276 | 1/20 | 0.33 |
| ▸ | RARB | P10826 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5986105 | 0.85 | ALDH1A1 (0.40) | ALDH1A1KDM4EHTTF2GAA | |
| SCHEMBL8293242 | 0.81 | RARA (0.48) | ALDH1A1KDM4EHTTF2GAA | |
| SCHEMBL17771804 | 0.79 | SIGMAR1 (0.38) | ALDH1A1GAASMN1; SMN2MAPTKMT2A | |
| SCHEMBL19805046 | 0.79 | ALDH1A1 (0.39) | ALDH1A1KDM4EHTTF2GAA | |
| SCHEMBL5536025 | 0.79 | NOTUM (0.31) | ALDH1A1KDM4EHTTF2GAA | |
| SCHEMBL5468863 | 0.79 | MAPT (0.38) | ALDH1A1KDM4EHTTGAASMN1; SMN2 | |
| SCHEMBL9917021 | 0.79 | SLC6A2 (0.42) | ALDH1A1KDM4E | |
| SCHEMBL17771703 | 0.79 | KDM4E (0.45) | ALDH1A1KDM4ESMN1; SMN2MAPTKMT2A | |
| SCHEMBL3308604 | 0.79 | NOTUM (0.43) | ALDH1A1KDM4ESMN1; SMN2LMNAPOLB | |
| SCHEMBL17771674 | 0.78 | NPSR1 (0.46) | HTTSMN1; SMN2MAPTLMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021155316-A1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. (US) | 2021-08-05 | — | — | WO | disclosed |
| US-20130087682-A1 | PHOTOELECTRIC CONVERSION DEVICE, IMAGING DEVICE, AND METHOD FOR DRIVING PHOTOELECTRIC CONVERSION DEVICE | FUJIFILM CORPORATION (JP) | 2013-04-11 | — | — | US | disclosed |
| US-20130087682-A1 | PHOTOELECTRIC CONVERSION DEVICE, IMAGING DEVICE, AND METHOD FOR DRIVING PHOTOELECTRIC CONVERSION DEVICE | FUJIFILM CORPORATION (JP) | 2013-04-11 | — | — | US | disclosed |
| EP-2570418-A2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-20 | — | — | EP | disclosed |
| US-8378101-B2 | Organic semiconductor, photoelectric conversion device, imaging device and novel compounds | FUJIFILM CORPORATION (JP) | 2013-02-19 | — | — | US | disclosed |
| US-8378101-B2 | Organic semiconductor, photoelectric conversion device, imaging device and novel compounds | FUJIFILM CORPORATION (JP) | 2013-02-19 | — | — | US | disclosed |
| EP-1555267-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES | OTSUKA PHARMA CO LTD (JP) | 2013-01-16 | — | — | EP | disclosed |
| US-8278650-B2 | Organic semiconductor, photoelectric conversion element and image device | FUJIFILM CORPORATION (JP) | 2012-10-02 | — | — | US | disclosed |
| US-8278650-B2 | Organic semiconductor, photoelectric conversion element and image device | FUJIFILM CORPORATION (JP) | 2012-10-02 | — | — | US | disclosed |
| US-20100102303-A1 | ORGANIC SEMICONDUCTOR, PHOTOELECTRIC CONVERSION DEVICE, IMAGING DEVICE AND NOVEL COMPOUNDS | FUJIFILM CORPORATION (JP) | 2010-04-29 | — | — | US | disclosed |
| US-20100102303-A1 | ORGANIC SEMICONDUCTOR, PHOTOELECTRIC CONVERSION DEVICE, IMAGING DEVICE AND NOVEL COMPOUNDS | FUJIFILM CORPORATION (JP) | 2010-04-29 | — | — | US | disclosed |
| US-20090283758-A1 | ORGANIC SEMICONDUCTOR, PHOTOELECTRIC CONVERSION ELEMENT AND IMAGE DEVICE | FUJIFILM CORPORATION (JP) | 2009-11-19 | — | — | US | disclosed |
| US-20090283758-A1 | ORGANIC SEMICONDUCTOR, PHOTOELECTRIC CONVERSION ELEMENT AND IMAGE DEVICE | FUJIFILM CORPORATION (JP) | 2009-11-19 | — | — | US | disclosed |
| US-7262212-B2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-08-28 | — | — | US | disclosed |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | NR2C2, NR4A3, NR4A2 | ALDH1A1 355/4885KDM4E 4854/4885HTT 4644/4885 |
| US-20100102303-A1 | ORGANIC SEMICONDUCTOR, PHOTOELECTRIC CONVERSION DEVICE, IMAGING DEVICE AND NOVEL COMPOUNDS | H1-3, H1-4, OR10J3 | ALDH1A1 2374/4885KDM4E 3316/4885HTT 2741/4885 |
| US-20090283758-A1 | ORGANIC SEMICONDUCTOR, PHOTOELECTRIC CONVERSION ELEMENT AND IMAGE DEVICE | H1-0, CCNE1, H1-4 | ALDH1A1 1793/4885KDM4E 2903/4885HTT 2896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.